Malignant pineal area germ cell neoplasm
diseaseOn this page
Also known as malignant germ cell neoplasm of pineal glandmalignant germ cell neoplasm of pineal parenchymamalignant germ cell neoplasm of the pineal glandmalignant germ cell neoplasm of the pineal parenchymamalignant germ cell tumor of pineal glandmalignant germ cell tumor of pineal parenchymamalignant germ cell tumor of the pineal glandmalignant germ cell tumor of the pineal parenchymamalignant germ cell tumour of pineal glandmalignant germ cell tumour of pineal parenchymamalignant germ cell tumour of the pineal glandmalignant germ cell tumour of the pineal parenchymamalignant pineal area germ cell tumormalignant pineal area germ cell tumourmalignant pineal gland germ cell neoplasmmalignant pineal gland germ cell tumormalignant pineal gland germ cell tumourmalignant pineal parenchymal germ cell neoplasmmalignant pineal parenchymal germ cell tumormalignant pineal parenchymal germ cell tumour
Summary
Malignant pineal area germ cell neoplasm (MONDO:0002073) is a cancer (an umbrella term covering 5 Mondo subtypes) and 1 clinical trial. Top therapeutic interventions include carboplatin. A subtype of central nervous system germ cell tumor — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
At a glance
- Classification: Cancer
- Umbrella term: 5 Mondo subtypes
- Clinical trials: 1
Clinical features
No curated clinical features (Orphanet) for this disease.
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | malignant pineal area germ cell neoplasm |
| Mondo ID | MONDO:0002073 |
| DOID | DOID:1660 |
| NCIT | C6767 |
| SNOMED CT | 277508009 |
| UMLS | C1334612 |
| MedGen | 233159 |
| GARD | 0012017 |
| Anatomy (UBERON) | UBERON:0001905 |
| Is cancer (heuristic) | yes |
Also known as: malignant germ cell neoplasm of pineal gland · malignant germ cell neoplasm of pineal parenchyma · malignant germ cell neoplasm of the pineal gland · malignant germ cell neoplasm of the pineal parenchyma · malignant germ cell tumor of pineal gland · malignant germ cell tumor of pineal parenchyma · malignant germ cell tumor of the pineal gland · malignant germ cell tumor of the pineal parenchyma · malignant germ cell tumour of pineal gland · malignant germ cell tumour of pineal parenchyma · malignant germ cell tumour of the pineal gland · malignant germ cell tumour of the pineal parenchyma · malignant pineal area germ cell tumor · malignant pineal area germ cell tumour · malignant pineal gland germ cell neoplasm · malignant pineal gland germ cell tumor · malignant pineal gland germ cell tumour · malignant pineal parenchymal germ cell neoplasm · malignant pineal parenchymal germ cell tumor · malignant pineal parenchymal germ cell tumour (+9 more)
Data availability: 1 cell line.
Disease family
This is a subtype of central nervous system germ cell tumor. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.
Classification path: disease › human disease › disease by body system or component › nervous system disorder › central nervous system disorder › central nervous system neoplasm › central nervous system germ cell tumor › malignant pineal area germ cell neoplasm
Related subtypes (5): central nervous system germinoma, adult central nervous system germ cell tumor, childhood central nervous system germ cell tumor, mixed germ cell tumor of central nervous system, central nervous system nongerminomatous germ cell tumor
Subtypes (5): pineal region yolk sac tumor, pineal region dysgerminoma, pineal region choriocarcinoma, pineal region immature teratoma, pineal region germinoma
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 1.
Phase distribution (across all retrieved trials)
| Phase | Trials |
|---|---|
| PHASE2 | 1 |
Top trials by phase / activity
| NCT | Phase | Status | Title |
|---|---|---|---|
| NCT06368817 | PHASE2 | RECRUITING | A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma |
Drugs tested across these trials (top 30)
| Molecule | Max phase | Trials referencing |
|---|---|---|
| CARBOPLATIN | 4 | 1 |
Related Atlas pages
- Drugs: Carboplatin